ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q1 2017. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $57,000 | +78.1% | 1,063 | +33.9% | 0.00% | – |
| Q3 2019 | $32,000 | +10.3% | 794 | +17.1% | 0.00% | – |
| Q2 2019 | $29,000 | -9.4% | 678 | 0.0% | 0.00% | – |
| Q1 2019 | $32,000 | +23.1% | 678 | +17.3% | 0.00% | – |
| Q4 2018 | $26,000 | +225.0% | 578 | +328.1% | 0.00% | – |
| Q3 2018 | $8,000 | +33.3% | 135 | -1.5% | 0.00% | – |
| Q2 2018 | $6,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 137 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | +50.0% | 137 | +44.2% | 0.00% | – |
| Q3 2017 | $4,000 | +33.3% | 95 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | +50.0% | 95 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | -50.0% | 95 | -18.8% | 0.00% | – |
| Q4 2016 | $4,000 | 0.0% | 117 | +3.5% | 0.00% | – |
| Q3 2016 | $4,000 | – | 113 | +769.2% | 0.00% | – |
| Q2 2016 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 13 | -53.6% | 0.00% | – |
| Q4 2015 | $1,000 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |